TCRX
USDTScan Therapeutics Inc. Common Stock
$1.120-0.050 (-4.274%)
Precio en Tiempo Real
Healthcare
Biotecnología
Estados Unidos
Gráfico de Precios
Loading Chart...
Métricas Clave
Métricas de Mercado
Apertura
$1.170
Máximo
$1.250
Mínimo
$1.080
Volumen
0.81M
Fundamentos de la Empresa
Capitalización de Mercado
63.6M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.51M
Bolsa
NGM
Moneda
USD
Rango de 52 Semanas
Mínimo $1.02Actual $1.120Máximo $6.225
Noticias Relacionadas
Analyst Upgrades
BTIG Downgrades TScan Therapeutics to Neutral
BTIG analyst Justin Zelin downgrades TScan Therapeutics from Buy to Neutral.
Ver más
Analyst Upgrades
Needham Maintains Buy on TScan Therapeutics, Lowers Price Target to $6
Needham analyst Gil Blum maintains TScan Therapeutics with a Buy and lowers the price target from $9 to $6.
Ver más
GlobeNewswire
TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027
Positive end of Phase I meeting and agreement reached with FDA on pivotal study design for TSC-101 Dosed first solid tumor patients with multiplex TCR-T therapy; paused further enrollment to prioritize heme development;
Ver más
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.